159 related articles for article (PubMed ID: 37410340)
1. Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Rencsok EM; Slopen N; Autio K; Morgans A; McSwain L; Barata P; Cheng HH; Dreicer R; Heath E; McKay RR; Pomerantz M; Rathkopf D; Tagawa S; Whang YE; Ragin C; Odedina FT; George DJ; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA;
Qual Life Res; 2023 Nov; 32(11):3209-3221. PubMed ID: 37410340
[TBL] [Abstract][Full Text] [Related]
2. Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Rencsok EM; Slopen N; McManus HD; Autio KA; Morgans AK; McSwain L; Barata P; Cheng HH; Dreicer R; Gerke T; Green R; Heath EI; Howard LE; McKay RR; Nowak J; Pileggi S; Pomerantz MM; Rathkopf DE; Tagawa ST; Whang YE; Ragin C; Odedina FT; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA; George DJ;
Cancer Res Commun; 2024 Jan; 4(1):55-64. PubMed ID: 38108490
[TBL] [Abstract][Full Text] [Related]
3. Experience with the US health care system for Black and White patients with advanced prostate cancer.
Rencsok EM; Stopsack KH; Slopen N; Odedina FT; Ragin C; Nowak J; McSwain L; Manarite J; Heath E; George DJ; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA;
Cancer; 2023 Aug; 129(16):2532-2541. PubMed ID: 37246339
[TBL] [Abstract][Full Text] [Related]
4. An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry.
Murphy AB
Cancer; 2023 Aug; 129(16):2453-2455. PubMed ID: 37246344
[TBL] [Abstract][Full Text] [Related]
5. Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor.
Lubeck DP; Kim H; Grossfeld G; Ray P; Penson DF; Flanders SC; Carroll PR
J Urol; 2001 Dec; 166(6):2281-5. PubMed ID: 11696752
[TBL] [Abstract][Full Text] [Related]
6. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
Koelker M; Labban M; Frego N; Ye J; Lipsitz SR; Hubbell HT; Edelen M; Steele G; Salinas K; Meyer CP; Makanjuola J; Moore CM; Cole AP; Kibel AS; Trinh QD
Prostate; 2024 Jan; 84(1):47-55. PubMed ID: 37710385
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for overall quality of life in patients with advanced cancer.
Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
10. High Levels of Medical Mistrust Are Associated With Low Quality of Life Among Black and White Men With Prostate Cancer.
Kinlock BL; Parker LJ; Bowie JV; Howard DL; LaVeist TA; Thorpe RJ
Cancer Control; 2017 Jan; 24(1):72-77. PubMed ID: 28178717
[TBL] [Abstract][Full Text] [Related]
11. Religious Coping and Quality of Life Among Black and White Men With Prostate Cancer.
Bruce MA; Bowie JV; Barge H; Beech BM; LaVeist TA; Howard DL; Thorpe RJ
Cancer Control; 2020; 27(3):1073274820936288. PubMed ID: 32638611
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans.
Knight SJ; Siston AK; Chmiel JS; Slimack N; Elstein AS; Chapman GB; Nadler RB; Bennett CL
Clin Prostate Cancer; 2004 Jun; 3(1):31-7. PubMed ID: 15279688
[TBL] [Abstract][Full Text] [Related]
14. Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life.
Orom H; Biddle C; Underwood W; Homish GG; Olsson CA
Urology; 2018 Feb; 112():132-137. PubMed ID: 28842210
[TBL] [Abstract][Full Text] [Related]
15. Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
Lynch SM; Sorice K; Tagai EK; Handorf EA
Cancer; 2020 Jan; 126(9):1949-1957. PubMed ID: 32012234
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
17. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01).
Holze S; Lemaire E; Mende M; Neuhaus P; Arthanareeswaran VK; Truss MC; Minh Do H; Dietel A; Teber D; Stützel KD; Hohenfellner M; Rabenalt R; Albers P; Stolzenburg JU
Prostate; 2022 Jun; 82(8):894-903. PubMed ID: 35254665
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
20. Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG).
Curran D; Fossa S; Aaronson N; Kiebert G; Keuppens F; Hall R
Eur J Cancer; 1997 Oct; 33(11):1809-14. PubMed ID: 9470838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
